Speed to market is a gold-standard goal for any prescription to over-the-counter drug switch. According to retail industry sources, French drug-maker Sanofi-Aventis received acclaim for moving its allergy prescription medication Allegra (fexofenadine hydrochloride), a second-generation antihistamine that is a fast, non-sedating and long-lasting treatment for seasonal allergic rhinitis (hay fever) and the treatment of uncomplicated hives, onto store shelves and in aisles. There were a ...

REGISTER TO VIEW THIS ARTICLE - Register for a Free Account

Why Register for FREE?

Registering for content on Supermarket News will give you INSTANT access to invaluable articles and media content that industry professionals rely on. You will have access to our special reports, feature articles, and industry analysis. It’s FREE, easy and quick.  What are you waiting for! In addition you will also receive a complimentary copy of SN's salary survey sent to you by email.
 

Click here to read the FAQ page if you have any questions (opens in a new window)
 

Attention Paid Print Subscribers:  While you have already been granted free access to SN we ask that you register now. We promise it will only take a few minutes! Or visit your profile and add your print magazine account number and zip code.

Already registered? here.